Morales Juliet A, Gant Sumner Zanetta, Hu Xiaohong, Johnson Lyons Shacara, Satcher Johnson Anna
U.S. Department of Energy, Research Participation Program, Oak Ridge Institute for Science and Education, Oak Ridge Associated Universities, Oak Ridge, TN, USA.
HIV Surveillance Branch, Division of HIV Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.
J Racial Ethn Health Disparities. 2024 Aug 19. doi: 10.1007/s40615-024-02133-7.
Assessing individual- and community-level factors may help to explain differences among Hispanic/Latino adults with diagnosed HIV not linked to care and without viral suppression in the United States.
We analyzed CDC's National HIV Surveillance System data among Hispanic/Latino persons aged ≥ 18 years with HIV diagnosed during 2021 in 47 states and the District of Columbia and linked cases via census tracts to the CDC/ATSDR's Social Vulnerability Index (SVI). Adjusted prevalence ratios and 95% confidence intervals for non-linkage to care and non-viral suppression were estimated using Poisson regression model.
Among 5,056 Hispanic/Latino adults with HIV diagnosed in 2021, 51.5% were born in the United States, 17.3% in Mexico, 9.2% in Central America, 11.1% in South America, 1.8% in Puerto Rico, 6.8% in Cuba, and 2.4% in the Caribbean. Compared with U.S.-born Hispanic/Latino adults, those born in Mexico and South America had a lower prevalence of non-linkage to care. Hispanic/Latino adults born in Mexico, South America, and the Caribbean (excluding Puerto Rico and Cuba) had a lower prevalence of non-viral suppression, compared with those born in the United States. No significant differences were observed among SVI quartiles for either care outcome.
This study aimed to challenge the narrow perspective on HIV care outcomes by examining the impact of birthplace and social vulnerability among Hispanic/Latino adults. To increase HIV care and prevention among Hispanic/Latino persons, research must evaluate health disparities within the group, and efforts are needed to better understand and tailor interventions within the diverse Hispanic/Latino population.
评估个体和社区层面的因素可能有助于解释在美国已确诊感染艾滋病毒但未接受治疗且病毒未得到抑制的西班牙裔/拉丁裔成年人之间的差异。
我们分析了疾病控制与预防中心(CDC)的国家艾滋病毒监测系统数据,这些数据来自2021年在47个州和哥伦比亚特区被诊断出感染艾滋病毒的年龄≥18岁的西班牙裔/拉丁裔人群,并通过人口普查区将病例与CDC/美国有毒物质和疾病登记署(ATSDR)的社会脆弱性指数(SVI)相联系。使用泊松回归模型估计未接受治疗和病毒未得到抑制的调整患病率比及95%置信区间。
在2021年被诊断出感染艾滋病毒的5056名西班牙裔/拉丁裔成年人中,51.5%出生在美国,17.3%出生在墨西哥,9.2%出生在中美洲,11.1%出生在南美洲,1.8%出生在波多黎各,6.8%出生在古巴,2.4%出生在加勒比地区。与在美国出生的西班牙裔/拉丁裔成年人相比,出生在墨西哥和南美洲的成年人未接受治疗的患病率较低。与在美国出生的成年人相比,出生在墨西哥、南美洲以及加勒比地区(不包括波多黎各和古巴)的西班牙裔/拉丁裔成年人病毒未得到抑制的患病率较低。在SVI四分位数组中,两种治疗结果均未观察到显著差异。
本研究旨在通过考察出生地和社会脆弱性对西班牙裔/拉丁裔成年人艾滋病毒治疗结果的影响,挑战对艾滋病毒治疗结果的狭隘看法。为了增加西班牙裔/拉丁裔人群中的艾滋病毒治疗和预防工作,研究必须评估该群体内部的健康差异,并且需要做出努力以更好地理解并针对多样化的西班牙裔/拉丁裔人群调整干预措施。